Association between prolactin increasing antipsychotic use and the risk of breast cancer: a retrospective observational cohort study in a United States Medicaid population

Autor: David M. Kern, Azza Shoaibi, David Shearer, Ute Richarz, Leslie Killion, R. Karl Knight

Publikováno v: Frontiers in Oncology, Vol 14 (2024)

IntroductionResults of retrospective studies examining the relationship between prolactin increasing antipsychotics and incident breast cancer have been inconsistent. This study assessed the association between use of high prolactin increasing antips

Externí odkaz: https://doaj.org/article/4c599318a5be4181aa9cf067055979e8

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

First-in-human study to assess the pharmacokinetics, tolerability, and safety of single-dose oxybutynin hydrochloride administered via a microprocessor-controlled intravaginal ring

Autor: Willem de Laat, Lisa Pagan, R. Karl Malcolm, Maarten Wiegerinck, Victor Nickolson, Bertine Huisman, Rik Stuurman, Michiel van Esdonk, Naomi Klarenbeek

Publikováno v: Drug Delivery, Vol 30, Iss 1 (2023)

AbstractPolymeric drug-releasing vaginal rings are useful for both local and systemic administration of drugs via the intravaginal route. Typically, they provide continuous sustained or controlled release of drug(s) over extended time periods, thereb

Externí odkaz: https://doaj.org/article/4787f941be144ec396a0d86999b07d4b

Erratum to: Combined analysis of Belle and Belle II data to determine the CKM angle ϕ 3 using B+ → D( K S 0 $$ {\textrm{K}}_{\textrm{S}}^0 $$ h+h − )h+ decays

Autor: The BELLE and Belle II collaborations, F. Abudinén, L. Aggarwal, H. Ahmed, H. Aihara, N. Akopov, S. Al Said, A. Aloisio, N. Anh Ky, D. M. Asner, H. Atmacan, V. Aushev, R. Ayad, V. Babu, S. Bacher, S. Baehr, S. Bahinipati, P. Bambade, Sw. Banerjee, S. Bansal, J. Baudot, J. Becker, P. K. Behera, K. Belous, J. V. Bennett, F. U. Bernlochner, M. Bertemes, E. Bertholet, M. Bessner, S. Bettarini, F. Bianchi, T. Bilka, D. Biswas, A. Bobrov, D. Bodrov, G. Bonvicini, J. Borah, A. Bozek, M. Bračko, P. Branchini, R. A. Briere, T. E. Browder, A. Budano, S. Bussino, M. Campajola, L. Cao, G. Casarosa, C. Cecchi, D. Červenkov, P. Cheema, V. Chekelian, A. Chen, B. G. Cheon, K. Chilikin, K. Chirapatpimol, H.-E. Cho, S.-J. Cho, S.-K. Choi, Y. Choi, S. Choudhury, D. Cinabro, L. Corona, S. Cunliffe, T. Czank, S. Das, F. Dattola, E. De La Cruz-Burelo, G. de Marino, S. K. Maurya, G. De Nardo, M. De Nuccio, G. De Pietro, R. de Sangro, M. Destefanis, S. Dey, A. De Yta-Hernandez, R. Dhamija, A. Di Canto, Z. Doležal, I. Domínguez Jiménez, T. V. Dong, M. Dorigo, D. Dossett, S. Dubey, G. Dujany, M. Eliachevitch, D. Epifanov, P. Feichtinger, D. Ferlewicz, T. Fillinger, S. Fiore, A. Fodor, F. Forti, B. G. Fulsom, A. Gabrielli, E. Ganiev, M. Garcia-Hernandez, V. Gaur, A. Gaz, R. Giordano, A. Giri, A. Glazov, R. Godang, P. Goldenzweig, B. Golob, W. Gradl, E. Graziani, D. Greenwald, T. Gu, Y. Guan, K. Gudkova, J. Guilliams, C. Hadjivasiliou, S. Halder, T. Hara, O. Hartbrich, K. Hayasaka, H. Hayashii, S. Hazra, I. Heredia de la Cruz, A. Hershenhorn, T. Higuchi, E. C. Hill, W.-S. Hou, C.-L. Hsu, T. Iijima, K. Inami, A. Ishikawa, M. Iwasaki, W. W. Jacobs, E.-J. Jang, Y. Jin, H. Junkerkalefeld, A. B. Kaliyar, K. H. Kang, R. Karl, G. Karyan, Y. Kato, C. Ketter, C. Kiesling, C.-H. Kim, D. Y. Kim, K.-H. Kim, Y.-K. Kim, K. Kinoshita, P. Kodyš, T. Koga, S. Kohani, S. Korpar, E. Kovalenko, T. M. G. Kraetzschmar, P. Križan, P. Krokovny, T. Kuhr, J. Kumar, M. Kumar, R. Kumar, K. Kumara, A. Kuzmin, Y.-J. Kwon, S. Lacaprara, Y.-T. Lai, C. La Licata, L. Lanceri, J. S. Lange, R. Leboucher, S. C. Lee, P. Leitl, J. Li, S. X. Li, L. Li Gioi, J. Libby, K. Lieret, Z. Liptak, Q. Y. Liu, D. Liventsev, S. Longo, T. Lueck, C. Lyu, M. Maggiora, R. Maiti, S. Maity, R. Manfredi, E. Manoni, S. Marcello, A. Martini, L. Massaccesi, M. Masuda, K. Matsuoka, D. Matvienko, J. A. McKenna, F. Meier, M. Merola, F. Metzner, M. Milesi, C. Miller, K. Miyabayashi, R. Mizuk, G. B. Mohanty, N. Molina-Gonzalez, H.-G. Moser, F. Mueller, C. Murphy, R. Mussa, K. R. Nakamura, T. Nakano, M. Nakao, M. Naruki, D. Narwal, A. Natochii, L. Nayak, M. Nayak, G. Nazaryan, N. K. Nisar, S. Nishida, K. Nishimura, Y. Onishchuk, H. Ono, P. Oskin, G. Pakhlova, A. Paladino, A. Panta, E. Paoloni, K. Parham, S.-H. Park, A. Passeri, A. Pathak, S. Patra, R. Pestotnik, L. E. Piilonen, T. Podobnik, S. Pokharel, L. Polat, C. Praz, S. Prell, E. Prencipe, M. T. Prim, H. Purwar, A. Rabusov, P. Rados, S. Raiz, S. Reiter, M. Remnev, I. Ripp-Baudot, G. Rizzo, L. B. Rizzuto, S. H. Robertson, M. Röhrken, J. M. Roney, A. Rostomyan, N. Rout, D. Sahoo, D. A. Sanders, S. Sandilya, L. Santelj, Y. Sato, V. Savinov, B. Scavino, G. Schnell, J. Schueler, A. J. Schwartz, Y. Seino, A. Selce, K. Senyo, M. E. Sevior, M. Shapkin, C. Sharma, T. Shillington, B. Shwartz, A. Sibidanov, F. Simon, J. B. Singh, A. Soffer, E. Solovieva, S. Spataro, B. Spruck, S. Stefkova, Z. S. Stottler, R. Stroili, K. Sumisawa, W. Sutcliffe, S. Y. Suzuki, M. Tabata, M. Takizawa, K. Tanida, F. Tenchini, R. Tiwary, D. Tonelli, E. Torassa, K. Trabelsi, M. Uchida, I. Ueda, T. Uglov, K. Uno, S. Uno, Y. Ushiroda, S. E. Vahsen, R. van Tonder, K. E. Varvell, A. Vinokurova, L. Vitale, H. M. Wakeling, E. Wang, M.-Z. Wang, X. L. Wang, A. Warburton, S. Watanuki, O. Werbycka, C. Wessel, E. Won, B. D. Yabsley, W. Yan, H. Ye, K. Yoshihara, Y. Yusa, L. Zani, Y. Zhai, Y. Zhang, V. Zhilich, Q. D. Zhou, X. Y. Zhou, V. I. Zhukova

Publikováno v: Journal of High Energy Physics, Vol 2022, Iss 12, Pp 1-5 (2022)

Externí odkaz: https://doaj.org/article/6ae8c67298024e22b1dc3bf73a26686a

Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia

Autor: Ibrahim Turkoz, Joshua Wong, Benjamin Chee, Uzma Siddiqui, R. Karl Knight, Ute Richarz, Christoph U. Correll

Publikováno v: Therapeutic Advances in Psychopharmacology, Vol 13 (2023)

Background: The paliperidone palmitate 6-month (PP6M) long-acting injectable formulation is currently the longest dosing interval available for schizophrenia treatment. Objective: To compare treatment outcomes between a real-world external comparator

Externí odkaz: https://doaj.org/article/50a28e7524cd4cc5bd7cf06f095c8f36